Thermo Fisher Scientific Inc

US

TMO

Health Care

548.38 ₽

Current price

Sell
548.38 ₽

Target price 00%

Ranks rating

76

  • Position in sub-industry

    133 / 240

  • Position in country

    9551 / 14179

  • Return on Assets, %

    6.2

    -2.7

  • Net income margin, %

    14.7

    -6.7

  • EBITDA margin, %

    25.4

    5.6

  • Debt to Equity, %

    74.7

    15.1

  • Intangible assets and goodwill, %

    61.4

    4.7

  • Revenue CAGR 3Y, %

    9.9

    12.8

  • Total Equity change 1Y, %

    6.2

    -2.4

  • Revenue Y, % chg

    -4.6

    0

  • P/E

    36.5

    32.1

  • P/BV

    4.6

    2

  • P/S

    5

    4.1

  • EV/S

    5.6

    3.6

  • EV/EBITDA

    22.5

    7.8

  • Average Analyst recommendation

    Hold

    Hold

  • Average upside forecasts, %

    7.5

    48.9

  • Forward P/E

    25.3

    25.5

  • Dividend Yield, %

    0.2

    0.8

  • Forward Dividend Yield, %

    0.2

    0.2

  • Expected dividend per share

    1.5

    0

  • Payout Ratio, %

    9

    10.1

  • Dividend Ex Date

    2024-03-14

Get an analytical review of this company

Competitors

Ranks

  • IQVIA Holdings Inc

    00%

  • West Pharmaceutical Services Inc

    00%

  • Agilent Technologies Inc

    00%

  • Avantor Inc

    00%

  • Thermo Fisher Scientific Inc

    00%

  • Danaher Corp

    00%

  • Waters Corp

    00%

  • Mettler-Toledo International Inc

    00%

  • Revvity Inc

    00%

  • Illumina Inc

    00%

Ready-made portfolio of the best Russian stocks

  • Created by artificial intelligence
  • Verified by analysts
  • Available even to beginners

Company information

  • Country

    United States of America

  • Sector

    Health Care

  • Industry group

    Pharmaceuticals, Biotechnology & Life Sciences

  • Industry

    Life Sciences Tools & Services

  • Sub-sector

    Health Care

  • Capitalization (millions of $)

    215529.1

  • Ticker

    TMO.N

  • ISIN

    US8835561023

  • IPO date

    1980-08-27

  • Availability on Russian exchanges

    Yes

  • Reporting for

    2024-02-22

  • Date fact. publication of reports

    2023-12-31

Company Description

Thermo Fisher Scientific Inc. develops, manufactures and sells a range of products. The Company operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services. It offers its products and services through various brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific and Unity Lab Services. Life Sciences Solutions segment provides a portfolio of reagents, instruments and consumables used in biological and medical research, discovery and production of new drugs and vaccines. Analytical Instruments segment provides a broad offering of instruments, consumables, software and services that are used for a range of applications in the laboratory. Specialty Diagnostics segment offers a wide range of diagnostic test kits, reagents, culture media, instruments and associated products. Its Laboratory Products and Services segment offers products and solutions needed for the laboratory.

A step towards better analytics

  • find the best promotions through the Screener
  • keep an eye on stock valuation
  • download detailed reports

and much more after free registration

Registration

More convenient from your phone? Download: